LOIS NARR: Open Payments
NPI 1437265014 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 20 payments from 10 companies in 2025. Trend: 2023 $272 · 2024 $379 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $70 |
| Lilly USA, LLC | 3 | $59 |
| PFIZER INC. | 3 | $58 |
| Exact Sciences Corporation | 2 | $51 |
| Astellas Pharma US Inc | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Dexcom, Inc. | 1 | $14 |
Products named: REXULTI, Cologuard Collection Kit, Veozah, ELIQUIS, MOUNJARO, OTEZLA, QULIPTA, KISUNLA.
Industry payments across MD — which companies pay providers there.
